Table 2 Host range of SDQ against different clinical isolates of S. aureus
From: Potential of bacteriophages as disinfectants to control of Staphylococcus aureus biofilms
Bacterial species | Strain | Phage Sensitivity | Strain Resource | MLST (ST) |
|---|---|---|---|---|
S. aureus | ATCC 43300 | + | ATCC | – |
|  | ATCC 29213 | + | ATCC | – |
|  | ATCC 25923 | + | ATCC | – |
|  | SA 2Y3–4 | + | Clinical isolate | 97 |
|  | SA 2Y9–1 | + | Clinical isolate | 97 |
|  | SA 2Y7–1 | + | Clinical isolate | 5817 |
|  | SA 2Y4–3 | + | Clinical isolate | 239 |
|  | SA 7–1 | – | Clinical isolate | 398 |
|  | SA 7–3 | + | Clinical isolate | 398 |
|  | SA 8–1 | – | Clinical isolate | 1 |
|  | SA 8–2 | – | Clinical isolate | 2154 |
|  | SA 8–3 | – | Clinical isolate | 9 |
|  | SA 25–4 | + | Clinical isolate | 239 |
|  | SA 25–5 | + | Clinical isolate | 97 |
|  | SA 27–2 | + | Clinical isolate | 5796 |
| Â | SA 4-2p | + | Clinical isolate | 5 |
| Â | SA-11-2-2p | + | Clinical isolate | 398 |
|  | SA11–1 | + | Clinical isolate | 97 |
|  | SA11–2 | + | Clinical isolate | 97 |
| Â | SA16b | + | Clinical isolate | 398 |
S. agalactiae | ATCC 13813 | – | ATCC | – |
L. monocytogenes | ATCC 19115 | – | ATCC | – |
E. faecalis | ATCC 29212 | – | ATCC | – |
S. Typhimurium | ATCC 14028 | – | ATCC | – |
P. mirabilis | CMCC 49005 | – | CMCC | – |
E. coli | ATCC 25922 | – | ATCC | – |